< Previous3032nd ECCMID Lisbon, Portugal – INTEGRATED SYMPOSIA AND EXHIBITION GUIDE Sunday, 24 April 2022 IS1408:30 - 10:30Integrated SymposiumHall N Conquer the case: integrating microbiological testing and the immune status of the host into clinical decision making ChairJose Maria Aguado Garcia (Madrid, Spain) Matteo Bassetti (Genoa, Italy) ESCMID-appointed chairEvgeny A. Idelevich (Greifswald, Germany) INT3409:30Welcome and introduction Jose Maria Aguado Garcia (Madrid, Spain) Matteo Bassetti (Genoa, Italy) Evgeny A. Idelevich (Greifswald, Germany) INT3509:32Opening remarks part 1 Matteo Bassetti (Genoa, Italy) INT3609:35Stepping up to the bedside of a challenging ICU pneumonia case Souha S. Kanj (Beirut, Lebanon) INT3709:53Is monotherapy for treatment of ICU gram-negative infections a thing of the past? Cornelius Clancy (Pittsburgh, United States) INT3810:11Panel discussion and Q&A part 1 Jose Maria Aguado Garcia (Madrid, Spain) Matteo Bassetti (Genoa, Italy) INT3910:29Opening remarks part 2 Jose Maria Aguado Garcia (Madrid, Spain) INT4010:32Managing infections in solid organ transplant patients: progress and pitfalls TBA INT4110:50Confronting CMV in HSCT: what have we learned and what’s next? Roy Chemaly (Houston, United States) INT4211:08Panel discussion and Q&A part 2 Jose Maria Aguado Garcia (Madrid, Spain) INT4311:26Closing remarks and Q&A Jose Maria Aguado Garcia (Madrid, Spain) Matteo Bassetti (Genoa, Italy) Evgeny A. Idelevich (Greifswald, Germany) Co-organised with:MSD31 INTEGRATED SYMPOSIA 32nd ECCMID Lisbon, Portugal – INTEGRATED SYMPOSIA AND EXHIBITION GUIDE Sunday, 24 April 2022 IS1508:30 - 10:30Integrated Symposium Hall L After the COVID-19 tide: exploring novel approaches in infectious diseases diagnostics from syndromic to immune testing ChairDavide Manissero (Hilden, Germany) ESCMID-appointed chairSophie Jarraud (Lyon, France) I06608:30Welcome and introduction Sophie Jarraud (Lyon, France) Davide Manissero (Hilden, Germany) I06708:35Two years into the COVID-19 pandemic: how has infectious diseases diagnostic testing evolved Benoit Visseaux (Hilden, Germany) I06808:55Syndromic testing for infectious diseases: opportunities and challenges Melissa Miller (Hilden, Germany) I06909:15Vaccine-induced immunity to COVID-19: role of T-cell responses Martina Sester (Hilden, Germany) I07009:35Is it what we predicted: did RSV and influenza return with a vengeance? Malin Grabbe (Sweden) I07109:55Clinical utility of cycle threshold (Ct) values: lessons learned from COVID-19 and application in the future Nathan Ledeboer (Milwaukee, United States) I07210:15Panel discussion and Q&A Sophie Jarraud (Lyon, France) Davide Manissero (Hilden, Germany) Co-organised with:QIAGEN3232nd ECCMID Lisbon, Portugal – INTEGRATED SYMPOSIA AND EXHIBITION GUIDE IS1608:30 - 10:30Integrated Symposium Hall M Spotlight on antifungals: are we well equipped for treating invasive fungal disease? ChairJohan Maertens (Leuven, Belgium) ESCMID-appointed chairMaiken Arendrup (Copenhagen, Denmark) I07308:30Welcome and introduction Maiken Arendrup (Copenhagen, Denmark) Johan Maertens (Leuven, Belgium) I07408:45The emergence and epidemiology of new fungal species Martin Hönigl (Graz, Austria) I07609:05Optimising the management of IFD to improve patient outcomes Malgorzata Mikulska (Genoa, Italy) I07709:25Improving outcomes in critically ill patients with invasive candidiasis Philippe Montravers (Paris, France) I07809:45The future of antifungals: a focuse on candidiasis Patricia Munoz (Madrid, Spain) I08010:10Panel discussion and Q&A Maiken Arendrup (Copenhagen, Denmark) Johan Maertens (Leuven, Belgium) I08110:25Close Maiken Arendrup (Copenhagen, Denmark) Johan Maertens (Leuven, Belgium) Co-organised with:Mundipharma Sunday, 24 April 202233 INTEGRATED SYMPOSIA 32nd ECCMID Lisbon, Portugal – INTEGRATED SYMPOSIA AND EXHIBITION GUIDE IS1708:30 - 10:30Integrated Symposium Hall P Facing a ‘new normal’: co-existence of SARS-CoV-2 and respiratory viruses ChairCarsten Tiemann (Bad Salzuflen, Germany) ESCMID-appointed chairDebby Bogaert (Edinburgh, United Kingdom) I08208:30Welcome and introduction Debby Bogaert (Edinburgh, United Kingdom) Carsten Tiemann (Bad Salzuflen, Germany) I08308:35Trend prediction and prospectives on respiratory disease in the “Living with COVID-19” and “Post COVID-19” era Yonat Shemer (Ramat Gan, Israel) I08409:00Support of Public Health Wales in the fight against SARS-CoV-2 variants Catherine Moore (Galway, Ireland) I08509:25Diagnostic stewardship for respiratory infections in a pediatric hospital: big challenge from single-virus mild infections to severe co-infections between SARS-CoV-2 and other respiratory viruses Cristian Perez-Corrales (San José, Costa Rica) I08609:50Discussion and Q&A Debby Bogaert (Edinburgh, United Kingdom) Carsten Tiemann (Bad Salzuflen, Germany) Co-organised with:Seegene Inc. Sunday, 24 April 20223432nd ECCMID Lisbon, Portugal – INTEGRATED SYMPOSIA AND EXHIBITION GUIDE IS1808:30 - 10:30Integrated Symposium Hall Q A Moment to Reset: harnessing learnings to tackle antimicrobial resistance in the community ChairPaulo Mergulhão (Porto, Portugal) ESCMID-appointed chairSanjay Patel (Southampton, United Kingdom) I08708:30Welcome and introduction Sanjay Patel (Southampton, United Kingdom) Paulo Mergulhão (Porto, Portugal) I08808:40A Moment to Reflect: the burden of AMR for patients Melissa Kramer (Leeds, United Kingdom) I08908:50A Moment to Respond: global AMR and epidemiology Aruna, Poojari (Mumbai, India) I09009:05A Moment to Realign: fighting antimicrobial resistance through prevention Leonard Friedland (Philadelphia, United States) I09109:20A Moment to Revier: AMR impact in community practice Paulo Mergulhão (Porto, Portugal) I09209:35A Moment to Reset: the economic impact of AMR John Rex (Wellesley, United States) I09309:50A Moment to take Responsibility: importance of public health Aruna Poojari (Mumbai, India) I09410:00Panel discussion and Q&A Sanjay Patel (Southampton, United Kingdom) Paulo Mergulhão (Porto, Portugal) Co-organised with:GSK Sunday, 24 April 202235 INTEGRATED SYMPOSIA 32nd ECCMID Lisbon, Portugal – INTEGRATED SYMPOSIA AND EXHIBITION GUIDE IS1912:15 - 13:15Integrated Symposium Hall L Control disease immediately: think C. difficle infection, think COVID! ChairMark Wilcox (Leeds, United Kingdom) ESCMID-appointed chairFidelma Fitzpatrick (Dublin, Ireland) I09512:15Welcome and introduction Fidelma Fitzpatrick (Dublin, Ireland) Mark Wilcox (Leeds, United Kingdom) I09612:20CDI an undefeated infection: focus on the organism John Coia (Esberg, Denmark) I09712:30CDI an undefeated infection: focus on control measures Frédéric Barbut (Paris, France) I09812:40Combatting CDI: focus on treatment and management Maria Vehreschild (Frankfurt Am Main, Germany) I09912:50Panel discussion and Q&A Fidelma Fitzpatrick (Dublin, Ireland) Mark Wilcox (Leeds, United Kingdom) I10013:10Summary Fidelma Fitzpatrick (Dublin, Ireland) Mark Wilcox (Leeds, United Kingdom) Co-organised with:Tillotts Pharma Sunday, 24 April 20223632nd ECCMID Lisbon, Portugal – INTEGRATED SYMPOSIA AND EXHIBITION GUIDE IS2012:15 - 13:15Integrated Symposium Hall N Staying ahead of the virus: evolving preventative strategies to manage COVID-19 variants ChairShabir Madhi (Johannesburg, South Africa) ESCMID-appointed chairJoel Mossong (Findel, Luxembourg) I10112:15Current outlook: a summary of the status of global COVID-19 prevention Joel Mossong (Findel, Luxembourg) Shabir Madhi (Johannesburg, South Africa) I10212:20COVID-19 prevention in practice: how are vaccines working in the real world? Barbara Rath (New Orleans, United States) I10312:40Vaccines and variants: remaining vigilant against COVID-19 Rajeka Lazarus (Bristol, United Kingdom) I10413:00Panel discussion and Q&A Joel Mossong (Findel, Luxembourg) Shabir Madhi (Johannesburg, South Africa) Co-organised with:AstraZeneca Sunday, 24 April 2022 MOLECULAR SOLUTIONS FOR RESULTS YOU CAN TRUST Automated solutions for laboratory and point of care for accurate and comprehensive infectious disease testing, transforming the delivery of better patient care & outcomes. Offering a wide range of versatile platforms, multiplex & rapid testing assays for respiratory, genitourinary and hospital acquired infections simultaneously detecting hundreds of targets from a single patient sample, for pathogen & mutation detection along with a range of SNP genotyping solutions. Complete IQC and EQA solutions for infectious disease testing. Leading the way to meet the needs of today’s molecular laboratory offering whole pathogen, flexible, multi-analyte and third-party material with organism traceability to WHO standards in over 100 countries. randox.com marketing@randox.com Visit store.randox.com to buy directly from Randox today Discover More at ECCMID 2022 23 rd – 26 th April 2022 Visit us at : PAVILION 3 STAND 2-19.1 Product availability may vary from country to country. Some products may be for Research use Only. For more information on product application and availability, please contact your local Randox Representative. ECCMID - A5 ad MAR22.indd 110/03/2022 17:32MOLECULAR SOLUTIONS FOR RESULTS YOU CAN TRUST Automated solutions for laboratory and point of care for accurate and comprehensive infectious disease testing, transforming the delivery of better patient care & outcomes. Offering a wide range of versatile platforms, multiplex & rapid testing assays for respiratory, genitourinary and hospital acquired infections simultaneously detecting hundreds of targets from a single patient sample, for pathogen & mutation detection along with a range of SNP genotyping solutions. Complete IQC and EQA solutions for infectious disease testing. Leading the way to meet the needs of today’s molecular laboratory offering whole pathogen, flexible, multi-analyte and third-party material with organism traceability to WHO standards in over 100 countries. randox.com marketing@randox.com Visit store.randox.com to buy directly from Randox today Discover More at ECCMID 2022 23 rd – 26 th April 2022 Visit us at : PAVILION 3 STAND 2-19.1 Product availability may vary from country to country. Some products may be for Research use Only. For more information on product application and availability, please contact your local Randox Representative. Ii Introducing Savanna Please visit the premiere at the Product Theater: Sunday15:30 Monday 10:30 Please also visit our booth: 2 12.1 (near theater) True Sample-to-Result Multiplex RT-PCR System :3832nd ECCMID Lisbon, Portugal – INTEGRATED SYMPOSIA AND EXHIBITION GUIDE IS2112:15 - 13:15Integrated Symposium Hall O Rapid AST on positive blood cultures: new standards in rapid susceptibility testing? ChairGérald Ulrich (Paris, France) ESCMID-appointed chairJordi Vila (Barcelona, Spain) I10512:15Welcome and introduction Gérald Ulrich (Paris, France) Jordi Vila (Barcelona, Spain) I10612:20Implementation of rapid AST: challenges and chances Ulrike Schumacher (Ravensburg, Germany) I10712:35Adoption of rapid AST: dramatic effect on blood culture work-flow Volkan Özenci (Stockholm, Sweden) I10812:50Rapid AST: laboratory improvements for the management of the patients Rafael Cantón (Madrid, Spain) I10913:05Panel discussion and Q&A Gérald Ulrich (Paris, France) Jordi Vila (Barcelona, Spain) Co-organised with:QuantaMatrix Inc. Sunday, 24 April 2022 Identifyspeciesfaster Targettherapysooner Reducelengthofstay SpeciesIDdirect fromwholeblood Stopwaitingdaysforbloodculture RapidCulture-IndependentDiagnosticsChartingaNewCourse forSepsisManagementandAntimicrobialStewardship Learnmoreat JoinusINTEGRATED SYMPOSIA Identifyspeciesfaster Targettherapysooner Reducelengthofstay SpeciesIDdirect fromwholeblood Stopwaitingdaysforbloodculture RapidCulture-IndependentDiagnosticsChartingaNewCourse forSepsisManagementandAntimicrobialStewardship Learnmoreat Joinus ZeptoMetrix is your end- to-end partner for high quality infectious disease controls and immunoassay solutions for your IVD diagnostic assays. FOR DX TEST DEVELOPERS THAT MUST GET IT RIGHT. Inactivated custom controls for internal use and end user controls/panels. MOLECULAR CONTROLS IMMUNOASSAY SOLUTIONS Custom antigens and antibodies for immunoassay development. MICROORGANISM COLLECTION Evolving collection of over 1200 distinct strains including SARS-CoV-2, influenza, STIs, HAIs and more. CONTROLS + IMMUNOASSAY + ORGANISMS VISIT US AT ECCMID IN LISBON APRIL 23-26 BOOTH #2.29 MORE INFO @ ZEPTOMETRIX.COM BOOTH #2.29 liiilIli:Next >